Vitamin D and Cancer Stem Cells in the Gastrointestinal Tract

Author(s): Ming-Xing Li, Long-Fei Li, Lin Zhang, Zan-Gang Xiao, Jing Shen, Wei Hu, Qiang Zeng, Chi-Hin Cho*

Journal Name: Current Medicinal Chemistry

Volume 24 , Issue 9 , 2017

  Journal Home
Translate in Chinese
Become EABM
Become Reviewer


Vitamin D has been widely used as a dietary supplement for the prevention and treatment of bone disorders. Epidemiological and preclinical studies demonstrated the anticancer action of vitamin D in a variety of cancers including those in the gastrointestinal (GI) tract. In these studies the inhibitory action of vitamin D on cancer stem cells (CSCs) has been a focus and is also an important subject to revolutionize the therapeutic potential of vitamin D on cancer treatment. Here, we summarize the involvement of CSC markers and factors and also their signaling pathways in the development of cancers in the esophagus, stomach, colon, pancreas and also liver. It is also evidenced that vitamin D could inhibit these markers and factors and their related signaling pathways to suppress tumor progression. All these information could provide new strategies in repurposing vitamin D as therapeutic agent to inhibit cancers in the GI tract.

Keywords: Vitamin D, gastrointestinal cancer, cancer stem cells, cancer stem cell markers, cancer microenvironment.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2017
Published on: 03 May, 2017
Page: [918 - 927]
Pages: 10
DOI: 10.2174/0929867324666170214110633
Price: $65

Article Metrics

PDF: 92